Viaderma Financials
| VDRM Stock | USD 0.01 0.0004 4.44% |
Viaderma |
Viaderma Stock Summary
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US92555K1016 |
| Business Address | 4640 Admiralty Way, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | viadermalicensing.com |
| Phone | 310 496 5744 |
| Currency | USD - US Dollar |
Viaderma Key Financial Ratios
There are many critical financial ratios that Viaderma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Viaderma reports annually and quarterly.| Return On Asset | -0.91 | |||
| Beta | -0.42 | |||
| Z Score | -28.3 |
Viaderma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Viaderma's current stock value. Our valuation model uses many indicators to compare Viaderma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Viaderma competition to find correlations between indicators driving Viaderma's intrinsic value. More Info.Viaderma is rated first in return on asset category among its peers. It is rated first in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Viaderma's earnings, one of the primary drivers of an investment's value.Viaderma Systematic Risk
Viaderma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Viaderma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Viaderma correlated with the market. If Beta is less than 0 Viaderma generally moves in the opposite direction as compared to the market. If Viaderma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Viaderma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Viaderma is generally in the same direction as the market. If Beta > 1 Viaderma moves generally in the same direction as, but more than the movement of the benchmark.
Viaderma December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Viaderma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Viaderma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Viaderma based on widely used predictive technical indicators. In general, we focus on analyzing Viaderma Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Viaderma's daily price indicators and compare them against related drivers.
| Downside Deviation | 15.31 | |||
| Information Ratio | 0.1021 | |||
| Maximum Drawdown | 72.22 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 25.0 |
Other Information on Investing in Viaderma Pink Sheet
Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.